BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15355378)

  • 1. Polidocanol or chromated glycerin for sclerotherapy of telangiectatic leg veins? With reply from Dr Kern et al.
    Noël B
    Dermatol Surg; 2004 Sep; 30(9):1272; author reply 1272-3. PubMed ID: 15355378
    [No Abstract]   [Full Text] [Related]  

  • 2. Postsclerotherapy hyperpigmentations. Chromated glycerin as a screen for patients at risk (a retrospective study).
    Georgiev M
    J Dermatol Surg Oncol; 1993 Jul; 19(7):649-52. PubMed ID: 8349903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins.
    Kern P; Ramelet AA; Wutschert R; Bounameaux H; Hayoz D
    Dermatol Surg; 2004 Mar; 30(3):367-72; discussion 372. PubMed ID: 15008862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins.
    Kern P; Ramelet AA; Wutschert R; Mazzolai L
    Dermatol Surg; 2011 Nov; 37(11):1590-4. PubMed ID: 21883648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins.
    Leach BC; Goldman MP
    Dermatol Surg; 2003 Jun; 29(6):612-4; discussion 615. PubMed ID: 12786704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
    Bush R; Bush P
    Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol.
    Künzlberger B; Pieck C; Altmeyer P; Stücker M
    Dermatol Surg; 2006 Nov; 32(11):1410-3. PubMed ID: 17083597
    [No Abstract]   [Full Text] [Related]  

  • 9. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel.
    Schuller-Petrović S; Pavlović MD; Schuller S; Schuller-Lukic B; Adamic M
    Phlebology; 2013 Sep; 28(6):320-3. PubMed ID: 22865418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
    Cameron E
    Dermatol Surg; 2012 Feb; 38(2):290. PubMed ID: 22309639
    [No Abstract]   [Full Text] [Related]  

  • 11. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
    Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA
    Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
    Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
    Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with Atoxisclerol in sclerotherapy].
    Cacciatore E
    Minerva Cardioangiol; 1979 Apr; 27(4):255-62. PubMed ID: 471250
    [No Abstract]   [Full Text] [Related]  

  • 14. Polidocanol (Varithena) for varicose veins.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):111-2. PubMed ID: 26218793
    [No Abstract]   [Full Text] [Related]  

  • 15. My sclerotherapy technique for telangiectasia and reticular veins.
    Goldman MP
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1040-5. PubMed ID: 20590711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual complication of facial sclerotherapy.
    Hoffman K
    Dermatol Surg; 2003 Apr; 29(4):423-4. PubMed ID: 12656827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.
    Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB
    Trials; 2014 Dec; 15():497. PubMed ID: 25527165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Micro-sclero-electrotherapy].
    Brizzio EO
    Phlebologie; 1991; 44(1):207-11. PubMed ID: 1946646
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline.
    Peterson JD; Goldman MP; Weiss RA; Duffy DM; Fabi SG; Weiss MA; Guiha I
    Dermatol Surg; 2012 Aug; 38(8):1322-30. PubMed ID: 22620717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed-dye laser treatment of leg telangiectasia: with and without simultaneous sclerotherapy.
    Goldman MP; Fitzpatrick RE
    J Dermatol Surg Oncol; 1990 Apr; 16(4):338-44. PubMed ID: 2324370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.